Alteration of Streptococcus salivarius in Buccal Mucosa of Oral Lichen Planus and Controlled Clinical Trial in OLP Treatment
Yuting Li,Fangyang Shao,Saiwei Zheng,Zhengwu Tan,Yuan He
DOI: https://doi.org/10.1007/s12602-020-09664-5
2020-06-06
Probiotics and Antimicrobial Proteins
Abstract:Oral lichen planus (OLP) is a T cell-mediated common chronic inflammatory mucosal disease, with limited therapies available for long-term use. Previous study showed that ratio of genus <i>Streptococcus</i> decreased significantly in OLP patients when compared with controls. Buccal cotton swab samples of 43 OLP patients and 48 healthy individuals were collected for real-time quantitative polymerase chain reaction (RT-PCR) to investigate relative abundance alteration of <i>Streptococcus salivarius</i> in OLP lesions. Bacterial supernatants of <i>S. salivarius</i> ATCC® BAA-2593™ were collected by centrifugation and added to HSC-3 cells, and quantitative analysis of expression of IL-1β, IL-6, IL-8, and TNF-α in the HSC-3 cells was determined by RT-PCR. Then, a randomized, non-blinded, controlled study was conducted. Forty patients with symptomatic OLP were randomly allocated into two groups and received topical treatment of 0.1% triamcinolone acetonide dental paste (group A) and <i>S. salivarius</i> K12 lozenge (group B), respectively, for 4 weeks. Sign scores, visual analogue scale (VAS), and adverse reactions were recorded. Relative abundance of <i>S. salivarius</i> in the OLP group was lower than that of control group (<i>P</i> < 0.05). After treated with 0.1% supernatants of <i>S. salivarius</i> ATCC® BAA-2593™, the expression level of IL-6 in the HSC-3 cells significantly reduced (<i>P</i> < 0.001), while IL-1β, IL-8, and TNF- α showed a decreasing tendency (<i>P</i> > 0.05). There was significant reduction in sign scores and VAS scores in both groups after the 4-week treatment, with no significant difference between two groups. No adverse reaction was observed. <i>S. salivarius</i> might maintain local immune balance by inhibiting the NF-κB pathway. Topical application of <i>Streptococcus salivarius</i> K12 seemed to be effective in treatment of symptomatic OLP, especially with promising potential in long-term use. More detailed clinical studies with long follow-up period and standardized usage/dosage are expected to acquire definite conclusions.
biotechnology & applied microbiology,microbiology